BioCentury | Jul 16, 2012
Company News

Echo Therapeutics, Ferndale Pharma Group deal

...previously eligible for a $750,000 payment upon FDA clearance. Echo Therapeutics Inc. (NASDAQ:ECTE), Philadelphia, Pa. Ferndale Pharma Group Inc....
BioCentury | Feb 13, 2012
Company News

Ferndale Pharma Group, Mission Pharmacal deal

...a dermatology-focused sales team to promote Eletone and other dermatology products. Details were not disclosed. Ferndale Pharma Group Inc....
BioCentury | Jan 2, 2012
Company News

Alliance Pharma, Ferndale Pharma Group sales and marketing update

...sales of about £600,000 ($934,501). Terms were not disclosed. Alliance Pharma plc (LSE:APH), Chippenham, U.K. Ferndale Pharma Group Inc....
BioCentury | Aug 1, 2011
Company News

Ferndale Pharma Group, Oculus sales and marketing update

...in gross profit from its Microcyn products business for the fiscal year ending March 31. Ferndale Pharma Group Inc....
BioCentury | Nov 22, 2010
Clinical News

Prelude SkinPrep System regulatory update

...to Echo from Ferndale (see BioCentury, June 8, 2009). Echo Therapeutics Inc. (OTCBB:ECTE), Franklin, Mass. Ferndale Pharma Group Inc....
BioCentury | May 10, 2010
Clinical News

Prelude SkinPrep System: Pivotal trial started

...market the product in North America and the U.K. Echo Therapeutics Inc. (OTCBB:ECTE), Franklin, Mass. Ferndale Pharma Group Inc....
BioCentury | Jun 8, 2009
Company News

Echo Therapeutics, Ferndale Pharma Group deal

...eligible for escalating royalties after the minimum is reached. Echo Therapeutics Inc. (OTCBB:ECTE), Franklin, Mass. Ferndale Pharma Group Inc....
BioCentury | Jun 9, 2008
Company News

Ferndale Pharma Group, Foamix deal

...for milestones and double-digit royalties. Further terms were not disclosed (see BioCentury, Nov. 12, 2007). Ferndale Pharma Group Inc....
BioCentury | Nov 12, 2007
Company News

Ferndale Pharma Group, Foamix deal

...has an option to further develop and commercialize the product. Further terms were not disclosed. Ferndale Pharma Group Inc....
BioCentury | May 28, 2007
Clinical News

Locoid hydrocortisone butyrate regulatory update

...to treat mild to moderate atopic dermatitis in patients 3 months of age and older. Ferndale Laboratories Inc....
Items per page:
1 - 10 of 12
BioCentury | Jul 16, 2012
Company News

Echo Therapeutics, Ferndale Pharma Group deal

...previously eligible for a $750,000 payment upon FDA clearance. Echo Therapeutics Inc. (NASDAQ:ECTE), Philadelphia, Pa. Ferndale Pharma Group Inc....
BioCentury | Feb 13, 2012
Company News

Ferndale Pharma Group, Mission Pharmacal deal

...a dermatology-focused sales team to promote Eletone and other dermatology products. Details were not disclosed. Ferndale Pharma Group Inc....
BioCentury | Jan 2, 2012
Company News

Alliance Pharma, Ferndale Pharma Group sales and marketing update

...sales of about £600,000 ($934,501). Terms were not disclosed. Alliance Pharma plc (LSE:APH), Chippenham, U.K. Ferndale Pharma Group Inc....
BioCentury | Aug 1, 2011
Company News

Ferndale Pharma Group, Oculus sales and marketing update

...in gross profit from its Microcyn products business for the fiscal year ending March 31. Ferndale Pharma Group Inc....
BioCentury | Nov 22, 2010
Clinical News

Prelude SkinPrep System regulatory update

...to Echo from Ferndale (see BioCentury, June 8, 2009). Echo Therapeutics Inc. (OTCBB:ECTE), Franklin, Mass. Ferndale Pharma Group Inc....
BioCentury | May 10, 2010
Clinical News

Prelude SkinPrep System: Pivotal trial started

...market the product in North America and the U.K. Echo Therapeutics Inc. (OTCBB:ECTE), Franklin, Mass. Ferndale Pharma Group Inc....
BioCentury | Jun 8, 2009
Company News

Echo Therapeutics, Ferndale Pharma Group deal

...eligible for escalating royalties after the minimum is reached. Echo Therapeutics Inc. (OTCBB:ECTE), Franklin, Mass. Ferndale Pharma Group Inc....
BioCentury | Jun 9, 2008
Company News

Ferndale Pharma Group, Foamix deal

...for milestones and double-digit royalties. Further terms were not disclosed (see BioCentury, Nov. 12, 2007). Ferndale Pharma Group Inc....
BioCentury | Nov 12, 2007
Company News

Ferndale Pharma Group, Foamix deal

...has an option to further develop and commercialize the product. Further terms were not disclosed. Ferndale Pharma Group Inc....
BioCentury | May 28, 2007
Clinical News

Locoid hydrocortisone butyrate regulatory update

...to treat mild to moderate atopic dermatitis in patients 3 months of age and older. Ferndale Laboratories Inc....
Items per page:
1 - 10 of 12